These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17525956)

  • 1. Hidden drugs, hidden risks--is cocaine use a new risk factor for stent thrombosis?
    Lemos PA
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):959-60. PubMed ID: 17525956
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.
    Singh S; Arora R; Khraisat A; Handa K; Bahekar A; Trivedi A; Khosla S
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):298-303. PubMed ID: 18172224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncardiac surgery after coronary stenting or angioplasty [corrected] .
    Tan WA
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):844-5. PubMed ID: 19902506
    [No Abstract]   [Full Text] [Related]  

  • 4. Late stent thrombosis--the "vulnerable" stent.
    Waksman R
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):54-6. PubMed ID: 17585385
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased incidence of stent thrombosis in patients with cocaine use.
    Karlsson G; Rehman J; Kalaria V; Breall JA
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):955-8. PubMed ID: 17492789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.
    Lemesle G; Sudre A; Modine T; Delhaye C; Rosey G; Gourlay T; Bauters C; Lablanche JM
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):470-8. PubMed ID: 18814219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCT Daily: new trials set to examine drug-eluting stents: doctors urged to weigh benefits, risks of drug-eluting stents on per patient basis.
    J Interv Cardiol; 2007 Feb; 20(1):33. PubMed ID: 17300397
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignancy: an unrecognized risk factor for coronary stent thrombosis?
    Hobson AR; McKenzie DB; Kunadian V; Purcell I; Zaman A; Dawkins KD; Curzen N
    J Invasive Cardiol; 2008 Apr; 20(4):E120-3. PubMed ID: 18398242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
    Olivier AC; Hollman JL
    J Invasive Cardiol; 2006 Jun; 18(6):E185-7. PubMed ID: 16775899
    [No Abstract]   [Full Text] [Related]  

  • 10. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-trouble: three cases with simultaneous stent thrombosis in different coronary arteries.
    van Werkum JW; Seesing TH; Suttorp MJ; Bal ET; den Heijer P; Ten Berg JM
    J Interv Cardiol; 2007 Apr; 20(2):132-5. PubMed ID: 17391221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late ischemic complications of PTCA.
    Ferguson JJ; Wilson JM
    J Invasive Cardiol; 1994; 6 Suppl A():3A-12A, discussion 43A-45A. PubMed ID: 10155092
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
    Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
    Waksman R; Weinberger J
    Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute coronary stent thrombosis: toward insights into possible mechanism using novel imaging methods.
    Zreiqat H; James B; Brieger D; Kritharides L; Lowe HC
    Thromb Haemost; 2008 May; 99(5):976-7. PubMed ID: 18449437
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel use in diabetic patients with new stents.
    Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent thrombosis after percutaneous coronary intervention for bifurcation lesions.
    Tan HC
    J Interv Cardiol; 2009 Apr; 22(2):114-6. PubMed ID: 19379468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.